Oncotarget New Antibody Removes Tregs to Boost Immune Response Against Cancer Treg play a deleterious role in the tumor microenvironment by suppressing anti-tumor effector T cells."... read more November 19, 2025
Oncotarget Immunotherapy Response Predicted by Machine Learning & Gut Microbiomes Researchers investigated common gut microbiome features of response among immunotherapy patients with different advanced-stage cancers.... read more September 1, 2022
Oncotarget Behind the Study: PRAME Associated with Increased Metastatic Risk Dr. Matthew G. Field discusses his 2016 study published by Oncotarget, entitled: “Epigenetic reprogramming and... read more June 7, 2021
Oncotarget Behind the Study: Extending Survival in Glioma Models Dr. Gregory Riggins from Johns Hopkins University discusses his 2017 study published by Oncotarget, entitled, "... read more May 10, 2021
Oncotarget New Analogs of Mibefradil Created as Radiosensitizers for Glioblastoma Researchers from Yale University conducted a study to create mibefradil analogs as superior radiosensitizers in... read more April 28, 2021
Oncotarget Trending with Impact: MSRE-PCR Detects Hypermethylated DNA in Tumors Researchers identify genomic regions in DNA with hypermethylation, abundant MSRE sites, and low methylation levels... read more November 24, 2020